pefloxacin has been researched along with Enterobacteriaceae Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archimbaud, E; Belhabri, A; Bouheddou, N; Fiere, D; Fleurette, J; Michallet, M; Pivot, C; Thiebaut, A; Thomas, X; Troncy, J | 1 |
| Chelfi, A; Liassine, N; Rahal, K | 1 |
| Boutelier, R; Guibert, J; Guyot, A | 1 |
| Chacon, JP; Criscuolo, PD; Ferraro, JR; Kobata, CM; Reis, C; Saad, SS | 1 |
| Block, C; Pitlik, SD; Rosen, N; Rubinstein, E; Segev, S | 1 |
| Argenson, C; Bernard, E; Dellamonica, P; Durant, J; Etesse-Carsenti, H; Mondain, V | 1 |
| Barzilai, A; Keren, G; Leibovitz, E; Rubinstein, E; Shabtai, M | 1 |
| Bellido, F; Lucain, C; Pechére, JC; Regamey, P | 1 |
| Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Ellis-Pegler, RB; Isaacs, RD | 1 |
| Bertrand, A; Janbon, F; Jonquet, O; Jourdan, J; Santoni, A | 1 |
| Aujard, Y; Bedu, A; Brisse, H; Farnoux, C; Le Huidoux, P; Naar, I | 1 |
5 trial(s) available for pefloxacin and Enterobacteriaceae Infections
| Article | Year |
|---|---|
[Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study].
Topics: Adult; Aged; Bacteremia; Bone Marrow Purging; Digestive System; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Pefloxacin; Treatment Outcome; Vancomycin | 2000 |
Prospective randomized comparison of pefloxacin and ampicillin plus gentamicin in the treatment of bacteriologically proven biliary tract infections.
Topics: Adolescent; Adult; Ampicillin; Cholangitis; Cholecystitis; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Middle Aged; Pefloxacin; Prospective Studies; Remission Induction | 1990 |
A randomized multicentre trial of pefloxacin plus metronidazole and gentamicin plus metronidazole in the treatment of severe intra-abdominal infections. Report from a Swedish Study Group.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Pefloxacin; Remission Induction | 1990 |
Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ceftazidime; Connective Tissue Diseases; Enterobacteriaceae Infections; Female; Humans; Immune Tolerance; Injections, Intravenous; Male; Middle Aged; Pefloxacin; Prospective Studies; Pseudomonas Infections; Remission Induction; Wound Infection | 1990 |
Pefloxacin in the treatment of bone infections associated with foreign material.
Topics: Bone and Bones; Enterobacteriaceae Infections; Female; Foreign Bodies; Humans; Male; Middle Aged; Osteitis; Pefloxacin; Pilot Projects; Pseudomonas Infections; Staphylococcal Infections | 1990 |
8 other study(ies) available for pefloxacin and Enterobacteriaceae Infections
| Article | Year |
|---|---|
[Resistance to new quinolones among the enterobacteria].
Topics: Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Nalidixic Acid; Ofloxacin; Pefloxacin; Recurrence; Urinary Tract Infections | 1992 |
A clinical trial of pefloxacin in prostatitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Pefloxacin; Prostatitis; Recurrence; Remission Induction; Time Factors | 1990 |
The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
Topics: Abscess; Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Enterobacteriaceae Infections; Female; Fleroxacin; Half-Life; Pefloxacin; Rats; Serratia marcescens | 1989 |
Resistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.
Topics: Animals; Bacterial Outer Membrane Proteins; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pefloxacin; Peritonitis; Plasmids | 1989 |
Combination therapy: a way to limit emergence of resistance?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1986 |
Successful treatment of Morganella morganii meningitis with pefloxacin mesylate.
Topics: Aged; Anti-Infective Agents; Enterobacteriaceae Infections; Female; Humans; Meningitis; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin | 1987 |
[Pefloxacin: clinical experience].
Topics: Acinetobacter Infections; Adult; Aged; Bacterial Infections; Enterobacteriaceae Infections; Enterococcus faecalis; Female; Humans; Male; Meningitis; Middle Aged; Norfloxacin; Osteitis; Pefloxacin; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1985 |
[Intracranial hypertension in a newborn treated with quinolone].
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Bacteremia; Ceftazidime; Child; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Infant, Newborn; Infant, Premature; Intracranial Hypertension; Male; Parenteral Nutrition; Pefloxacin; Quinolones; Remission, Spontaneous | 1998 |